Wellington Management Group’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.9M Buy
179,886
+166,183
+1,213% +$2.68M ﹤0.01% 1490
2025
Q1
$288K Sell
13,703
-431
-3% -$9.05K ﹤0.01% 1868
2024
Q4
$352K Buy
+14,134
New +$352K ﹤0.01% 1842
2020
Q4
Sell
-36,773
Closed -$11.3M 1953
2020
Q3
$11.3M Sell
36,773
-8,811
-19% -$2.7M ﹤0.01% 1076
2020
Q2
$17.1M Sell
45,584
-2,735
-6% -$1.03M ﹤0.01% 957
2020
Q1
$11M Buy
48,319
+11,259
+30% +$2.57M ﹤0.01% 1016
2019
Q4
$19.6M Sell
37,060
-1,513
-4% -$800K ﹤0.01% 999
2019
Q3
$16.6M Sell
38,573
-9,050
-19% -$3.9M ﹤0.01% 1017
2019
Q2
$56.8M Sell
47,623
-2,024
-4% -$2.41M 0.01% 719
2019
Q1
$61.9M Sell
49,647
-3,546
-7% -$4.42M 0.01% 681
2018
Q4
$50.4M Sell
53,193
-3,541
-6% -$3.35M 0.01% 705
2018
Q3
$81.7M Buy
56,734
+810
+1% +$1.17M 0.02% 651
2018
Q2
$90.2M Sell
55,924
-1,951
-3% -$3.15M 0.02% 605
2018
Q1
$93.9M Buy
57,875
+22,091
+62% +$35.9M 0.02% 591
2017
Q4
$60.1M Buy
35,784
+835
+2% +$1.4M 0.01% 716
2017
Q3
$48.9M Buy
34,949
+444
+1% +$621K 0.01% 760
2017
Q2
$38.5M Buy
34,505
+2,337
+7% +$2.61M 0.01% 811
2017
Q1
$17.5M Buy
32,168
+4,169
+15% +$2.26M ﹤0.01% 1081
2016
Q4
$17.1M Buy
27,999
+371
+1% +$226K ﹤0.01% 1051
2016
Q3
$19.8M Buy
27,628
+525
+2% +$375K ﹤0.01% 986
2016
Q2
$19.7M Buy
27,103
+413
+2% +$300K 0.01% 950
2016
Q1
$15.9M Buy
26,690
+436
+2% +$260K ﹤0.01% 998
2015
Q4
$15M Buy
26,254
+27
+0.1% +$15.4K ﹤0.01% 1045
2015
Q3
$14.7M Buy
26,227
+27
+0.1% +$15.1K ﹤0.01% 1055
2015
Q2
$20.8M Buy
26,200
+6
+0% +$4.77K 0.01% 1006
2015
Q1
$21.8M Buy
26,194
+204
+0.8% +$170K 0.01% 1014
2014
Q4
$18.7M Sell
25,990
-64
-0.2% -$46.1K ﹤0.01% 1067
2014
Q3
$18.1M Buy
26,054
+1,962
+8% +$1.36M 0.01% 1059
2014
Q2
$20.3M Sell
24,092
-372
-2% -$314K 0.01% 1031
2014
Q1
$40M Buy
+24,464
New +$40M 0.01% 816